HITAP-ADP Webinar | Online Tools

Home > Webinars of HITAP > HITAP-ADP Webinar | Online Tools

How best can we take on the urgent and long-term healthcare needs of our countries? By learning together! HITAP, the United Nations Development Programme (UNDP) and the Access and Delivery Partnership (ADP) present you a three-part webinar series where, from across different contexts, we will look at the application of evidence in an intervention’s life cycle: from identification and prioritization, to procurement and price negotiation, and, finally, to implementation and monitoring and evaluation.

Part 1 - Identification and prioritisation of health technologies

Part 2 - Procurement of health technologies and price negotiations

Part 3 - Implementation and Monitoring and Evaluation (M&E)

Introduction

Identification and prioritisation of health technologies

Watch full recorded video of the webinar

Designing the Health Benefit Package: The essential component of a successful universal health coverage program

Is it Worthwhile to Introduce Pneumococcal Conjugate Vaccine into the Routine Immunization Services?

Priority setting: the need, the practice, the challenge

Reading List

Culyer, Anthony J., and Jonathan Lomas. “Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know?.” Evidence & Policy: A Journal of Research, Debate and Practice3 (2006): 357-371.
Culyer, Anthony J. “Involving stakeholders in health care decisions–the experience of the National Institute for Clinical Excellence (NICE) in England and Wales.” Healthc Q3 (2005): 54-8.
Lomas, Jonathan, Tony Culyer, and Chris McCutcheon. Conceptualizing and combining evidence for health system guidance. Canadian Health Services Research Foundation, 2005.
Chalkidou, Kalipso, et al. “Priority-setting for achieving universal health coverage.” Bulletin of the World Health Organization6 (2016): 462.
Teerawattananon, Yot, et al. “Role of priority setting in implementing universal health coverage.” (2016): i244.

*The webinar materials can be accessed from the ADP website

Part 2

Procurement of health technologies and price negotiations

Watch full recorded video of the webinar

Budgeting and paying for services under Thailand’s Universal Coverage Scheme

Thailand-Vietnam Experience Sharing Workshop on National Centralized Drug Procurement and Price Negotiation

The Role of Health Technology Assessment in Medicine Pricing and Reimbursement

Reading List

Teerawattananon Y, Tritasavit N, Suchonwanich N, Kingkaew P. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):397-404. doi:10.1016/j.zefq.2014.06.017
Teerawattananon, N. Tritasavit. A learning experience from price negotiations for vaccines. Vaccine, 33 (Suppl 1) (2015), pp. A11-A12, 10.1016/j.vaccine.2014.12.050
Parkinson B, Sermet C, Clement F, et al. Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. Pharmacoeconomics. 2015;33(9):905-924. doi:10.1007/s40273-015-0293-8
Hollingworth S, Gyansa-Lutterodt M, Dsane-Selby L, et al. Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process. Int J Technol Assess Health Care. 2020;36(1):8-11. doi:10.1017/S0266462319000795
Callea G, Armeni P, Marsilio M, Jommi C, Tarricone R. The impact of HTA and procurement practices on the selection and prices of medical devices. Soc Sci Med. 2017;174:89-95. doi:10.1016/j.socscimed.2016.11.038
Vogler S, Paris V, Panteli D, Richardson E, Palm W, Mossialos E, eds. Ensuring access to medicines: How to redesign pricing, reimbursement and procurement?. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2018.
Tanvejsilp P, Taychakhoonavudh S, Chaikledkaew U, Chaiyakunapruk N, Ngorsuraches S. Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?. Value Health Reg Issues. 2019;18:78-82. doi:10.1016/j.vhri.2018.11.004

*The webinar materials can be accessed from the ADP website

Part 3

Implementation and Monitoring and Evaluation (M&E)

Watch full recorded video of the webinar

Using Health Technology Assessment to address inefficient and unequal use of Nilotinib across Indonesia

Economic Evaluation of the Implementation of the WHO Package of Essential Non-Communicable Disease (PEN) Interventions in Indonesia

Who are the high cost users in Thailand’s Universal Coverage Scheme and how can we help?

Reading List

ADP Heath. TDR Implementation Research Toolkit.
http://adphealth.org/irtoolkit/
Gad, Mohamed et al.Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana. Value in Health, Volume 23, Issue 2, 171 – 179 (2019).
https://www.valueinhealthjournal.com/article/S1098-3015(19)35131-9/fulltext
Lilyasari, O., Subekti, Y., Atika, N. et al. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia. BMC Health Serv Res 19, 573 (2019). https://doi.org/10.1186/s12913-019-4422-5
Peters David H, Adam Taghreed, Alonge Olakunle, Agyepong Irene Akua, Tran Nhan. Implementation research: what it is and how to do it BMJ 2013; 347 :f6753
https://www.bmj.com/content/347/bmj.f6753
Teerawattananon Yot, Dabak Saudamini Vishwanath, Khoe Levina Chandra, Bayani Diana Beatriz S, Isaranuwatchai Wanrudee. To include or not include: renal dialysis policy in the era of universal health coverage BMJ 2020; 368 :m82
https://www.bmj.com/content/368/bmj.m82

*The webinar materials can be accessed from the ADP website

Top

HITAP เข้าสู่ระบบ

HITAP-ADP Webinar | Online Tools

Please select the topic

Introduction

Identification and prioritisation of health technologies

Culyer, Anthony J., and Jonathan Lomas. “Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know?.” Evidence & Policy: A Journal of Research, Debate and Practice3 (2006): 357-371.

Culyer, Anthony J. “Involving stakeholders in health care decisions–the experience of the National Institute for Clinical Excellence (NICE) in England and Wales.” Healthc Q3 (2005): 54-8.

Lomas, Jonathan, Tony Culyer, and Chris McCutcheon. Conceptualizing and combining evidence for health system guidance. Canadian Health Services Research Foundation, 2005.

Chalkidou, Kalipso, et al. “Priority-setting for achieving universal health coverage.” Bulletin of the World Health Organization6 (2016): 462.

Teerawattananon, Yot, et al. “Role of priority setting in implementing universal health coverage.” (2016): i244.

*The webinar materials can be accessed from the ADP website

Procurement of health technologies and price negotiations

Teerawattananon Y, Tritasavit N, Suchonwanich N, Kingkaew P. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):397-404. doi:10.1016/j.zefq.2014.06.017

Teerawattananon, N. Tritasavit. A learning experience from price negotiations for vaccines. Vaccine, 33 (Suppl 1) (2015), pp. A11-A12, 10.1016/j.vaccine.2014.12.050

Parkinson B, Sermet C, Clement F, et al. Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. Pharmacoeconomics. 2015;33(9):905-924. doi:10.1007/s40273-015-0293-8

Hollingworth S, Gyansa-Lutterodt M, Dsane-Selby L, et al. Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process. Int J Technol Assess Health Care. 2020;36(1):8-11. doi:10.1017/S0266462319000795

Callea G, Armeni P, Marsilio M, Jommi C, Tarricone R. The impact of HTA and procurement practices on the selection and prices of medical devices. Soc Sci Med. 2017;174:89-95. doi:10.1016/j.socscimed.2016.11.038

Vogler S, Paris V, Panteli D, Richardson E, Palm W, Mossialos E, eds. Ensuring access to medicines: How to redesign pricing, reimbursement and procurement?. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2018.

Tanvejsilp P, Taychakhoonavudh S, Chaikledkaew U, Chaiyakunapruk N, Ngorsuraches S. Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?. Value Health Reg Issues. 2019;18:78-82. doi:10.1016/j.vhri.2018.11.004

*The webinar materials can be accessed from the ADP website

Implementation and Monitoring and Evaluation (M&E)

ADP Heath. TDR Implementation Research Toolkit.

Gad, Mohamed et al.Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana. Value in Health, Volume 23, Issue 2, 171 – 179 (2019).

Lilyasari, O., Subekti, Y., Atika, N. et al. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia. BMC Health Serv Res 19, 573 (2019). https://doi.org/10.1186/s12913-019-4422-5

Peters David H, Adam Taghreed, Alonge Olakunle, Agyepong Irene Akua, Tran Nhan. Implementation research: what it is and how to do it BMJ 2013; 347 :f6753

Teerawattananon Yot, Dabak Saudamini Vishwanath, Khoe Levina Chandra, Bayani Diana Beatriz S, Isaranuwatchai Wanrudee. To include or not include: renal dialysis policy in the era of universal health coverage BMJ 2020; 368 :m82

*The webinar materials can be accessed from the ADP website

Menu

Follow Us On

Subscribe to our mailing list

Subscribe to our mailing list

Lilyasari, O., Subekti, Y., Atika, N. et al. Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia. BMC Health Serv Res 19, 573 (2019). https://doi.org/10.1186/s12913-019-4422-5